nodes	percent_of_prediction	percent_of_DWPC	metapath
Labetalol—hypertension—chronic kidney failure	0.957	1	CtDrD
Labetalol—Benazepril—MTHFR—chronic kidney failure	0.00043	0.0842	CrCbGaD
Labetalol—Quinapril—ACE—chronic kidney failure	0.000403	0.0789	CrCbGaD
Labetalol—Benazepril—ACE—chronic kidney failure	0.000351	0.0687	CrCbGaD
Labetalol—Formoterol—CYP2C19—chronic kidney failure	0.000314	0.0615	CrCbGaD
Labetalol—Arformoterol—CYP2C19—chronic kidney failure	0.000314	0.0615	CrCbGaD
Labetalol—Salsalate—PTGS1—chronic kidney failure	0.000309	0.0606	CrCbGaD
Labetalol—Fenoprofen—PTGS1—chronic kidney failure	0.000256	0.0501	CrCbGaD
Labetalol—Mirabegron—CYP3A4—chronic kidney failure	0.00025	0.0489	CrCbGaD
Labetalol—Salmeterol—CYP3A4—chronic kidney failure	0.000228	0.0447	CrCbGaD
Labetalol—Mirabegron—ALB—chronic kidney failure	0.000218	0.0427	CrCbGaD
Labetalol—Mirabegron—ABCB1—chronic kidney failure	0.000208	0.0407	CrCbGaD
Labetalol—Tolterodine—CYP2C19—chronic kidney failure	0.000206	0.0404	CrCbGaD
Labetalol—Salsalate—PTGS2—chronic kidney failure	0.000177	0.0346	CrCbGaD
Labetalol—Isoprenaline—CYP1A1—chronic kidney failure	0.000168	0.0329	CrCbGaD
Labetalol—Flurbiprofen—PTGS1—chronic kidney failure	0.000167	0.0327	CrCbGaD
Labetalol—Ketoprofen—PTGS1—chronic kidney failure	0.000151	0.0295	CrCbGaD
Labetalol—Fenoprofen—PTGS2—chronic kidney failure	0.000146	0.0286	CrCbGaD
Labetalol—Tolterodine—CYP3A4—chronic kidney failure	0.000131	0.0257	CrCbGaD
Labetalol—Fenoprofen—ALB—chronic kidney failure	0.00013	0.0255	CrCbGaD
Labetalol—Propafenone—CYP3A4—chronic kidney failure	0.000112	0.0219	CrCbGaD
Labetalol—Flurbiprofen—PTGS2—chronic kidney failure	9.53e-05	0.0187	CrCbGaD
Labetalol—Propafenone—ABCB1—chronic kidney failure	9.28e-05	0.0182	CrCbGaD
Labetalol—Ketoprofen—PTGS2—chronic kidney failure	8.62e-05	0.0169	CrCbGaD
Labetalol—Flurbiprofen—ALB—chronic kidney failure	8.49e-05	0.0166	CrCbGaD
Labetalol—Ketoprofen—ALB—chronic kidney failure	7.68e-05	0.015	CrCbGaD
Labetalol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCR5—chronic kidney failure	5.13e-05	0.00136	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—CRHR1—chronic kidney failure	5.05e-05	0.00134	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—PRKAG2—chronic kidney failure	5.05e-05	0.00134	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—CRHR1—chronic kidney failure	4.94e-05	0.00131	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—COL4A3—chronic kidney failure	4.78e-05	0.00127	CbGpPWpGaD
Labetalol—ADRB1—GPCR ligand binding—AVP—chronic kidney failure	4.69e-05	0.00124	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—HBEGF—chronic kidney failure	4.68e-05	0.00124	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—PTH—chronic kidney failure	4.62e-05	0.00122	CbGpPWpGaD
Labetalol—ADRB2—GPCR ligand binding—AVP—chronic kidney failure	4.59e-05	0.00121	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—CRHR1—chronic kidney failure	4.59e-05	0.00121	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—CRHR1—chronic kidney failure	4.56e-05	0.00121	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—PTH—chronic kidney failure	4.52e-05	0.0012	CbGpPWpGaD
Labetalol—ADRB1—Class A/1 (Rhodopsin-like receptors)—F2—chronic kidney failure	4.5e-05	0.00119	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—CRHR1—chronic kidney failure	4.49e-05	0.00119	CbGpPWpGaD
Labetalol—ADRB3—GPCR downstream signaling—AVP—chronic kidney failure	4.47e-05	0.00118	CbGpPWpGaD
Labetalol—ADRB1—GPCR ligand binding—EDN1—chronic kidney failure	4.47e-05	0.00118	CbGpPWpGaD
Labetalol—ADRB1—GPCR ligand binding—CCL5—chronic kidney failure	4.43e-05	0.00117	CbGpPWpGaD
Labetalol—ADRB2—Class A/1 (Rhodopsin-like receptors)—F2—chronic kidney failure	4.4e-05	0.00116	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—LRP2—chronic kidney failure	4.38e-05	0.00116	CbGpPWpGaD
Labetalol—ADRB2—GPCR ligand binding—EDN1—chronic kidney failure	4.37e-05	0.00116	CbGpPWpGaD
Labetalol—CYP2D6—Biological oxidations—CYP1A1—chronic kidney failure	4.35e-05	0.00115	CbGpPWpGaD
Labetalol—ADRB2—GPCR ligand binding—CCL5—chronic kidney failure	4.33e-05	0.00115	CbGpPWpGaD
Labetalol—CYP2D6—Metapathway biotransformation—CYP1A1—chronic kidney failure	4.29e-05	0.00113	CbGpPWpGaD
Labetalol—ADRB3—GPCR downstream signaling—EDN1—chronic kidney failure	4.25e-05	0.00112	CbGpPWpGaD
Labetalol—ADRB3—GPCR downstream signaling—CCL5—chronic kidney failure	4.22e-05	0.00112	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—PTH—chronic kidney failure	4.19e-05	0.00111	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—PTH—chronic kidney failure	4.17e-05	0.0011	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—PTH—chronic kidney failure	4.1e-05	0.00109	CbGpPWpGaD
Labetalol—ADRB1—Class A/1 (Rhodopsin-like receptors)—POMC—chronic kidney failure	4.1e-05	0.00108	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—CYBB—chronic kidney failure	4.07e-05	0.00108	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—AVP—chronic kidney failure	4.06e-05	0.00107	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—NPY—chronic kidney failure	4.01e-05	0.00106	CbGpPWpGaD
Labetalol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCL2—chronic kidney failure	4.01e-05	0.00106	CbGpPWpGaD
Labetalol—ADRB2—Class A/1 (Rhodopsin-like receptors)—POMC—chronic kidney failure	4.01e-05	0.00106	CbGpPWpGaD
Labetalol—ADRB1—GPCR ligand binding—CCR5—chronic kidney failure	3.99e-05	0.00106	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—NPY—chronic kidney failure	3.92e-05	0.00104	CbGpPWpGaD
Labetalol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCL2—chronic kidney failure	3.92e-05	0.00104	CbGpPWpGaD
Labetalol—ADRB2—GPCR ligand binding—CCR5—chronic kidney failure	3.9e-05	0.00103	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—OXT—chronic kidney failure	3.87e-05	0.00102	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—CRH—chronic kidney failure	3.87e-05	0.00102	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—EDN1—chronic kidney failure	3.86e-05	0.00102	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—FGF23—chronic kidney failure	3.85e-05	0.00102	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—COL4A5—chronic kidney failure	3.85e-05	0.00102	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—CCL5—chronic kidney failure	3.83e-05	0.00101	CbGpPWpGaD
Labetalol—ADRB3—GPCR downstream signaling—CCR5—chronic kidney failure	3.8e-05	0.00101	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—CRH—chronic kidney failure	3.79e-05	0.001	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—OXT—chronic kidney failure	3.79e-05	0.001	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—COL4A5—chronic kidney failure	3.76e-05	0.000995	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—NPS—chronic kidney failure	3.67e-05	0.000971	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—NPY—chronic kidney failure	3.64e-05	0.000964	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—NPY—chronic kidney failure	3.63e-05	0.000959	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—DRD1—chronic kidney failure	3.6e-05	0.000952	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—NPS—chronic kidney failure	3.59e-05	0.00095	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—TFDP2—chronic kidney failure	3.57e-05	0.000946	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—NPY—chronic kidney failure	3.56e-05	0.000943	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—DRD1—chronic kidney failure	3.52e-05	0.000931	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—OXT—chronic kidney failure	3.52e-05	0.00093	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—CRH—chronic kidney failure	3.52e-05	0.00093	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—CRH—chronic kidney failure	3.5e-05	0.000925	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—OXT—chronic kidney failure	3.5e-05	0.000925	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—PIP5K1B—chronic kidney failure	3.5e-05	0.000925	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—TFDP2—chronic kidney failure	3.5e-05	0.000925	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—CCR5—chronic kidney failure	3.45e-05	0.000913	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—CRH—chronic kidney failure	3.44e-05	0.00091	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—OXT—chronic kidney failure	3.44e-05	0.00091	CbGpPWpGaD
Labetalol—ADRB1—GPCR ligand binding—F2—chronic kidney failure	3.42e-05	0.000906	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—PIP5K1B—chronic kidney failure	3.42e-05	0.000905	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—NCF1—chronic kidney failure	3.35e-05	0.000886	CbGpPWpGaD
Labetalol—ADRB2—GPCR ligand binding—F2—chronic kidney failure	3.35e-05	0.000886	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—NPS—chronic kidney failure	3.33e-05	0.000881	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—NPS—chronic kidney failure	3.32e-05	0.000877	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—DRD1—chronic kidney failure	3.27e-05	0.000864	CbGpPWpGaD
Labetalol—ADRB3—GPCR downstream signaling—F2—chronic kidney failure	3.26e-05	0.000863	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—NPS—chronic kidney failure	3.26e-05	0.000862	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—DRD1—chronic kidney failure	3.25e-05	0.00086	CbGpPWpGaD
Labetalol—CYP2D6—Biological oxidations—POMC—chronic kidney failure	3.24e-05	0.000857	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—DRD1—chronic kidney failure	3.2e-05	0.000846	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—PGF—chronic kidney failure	3.19e-05	0.000843	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—CYBA—chronic kidney failure	3.15e-05	0.000833	CbGpPWpGaD
Labetalol—ADRB1—GPCR ligand binding—POMC—chronic kidney failure	3.12e-05	0.000825	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—PGF—chronic kidney failure	3.12e-05	0.000824	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—FABP1—chronic kidney failure	3.06e-05	0.000808	CbGpPWpGaD
Labetalol—ADRB1—GPCR ligand binding—CCL2—chronic kidney failure	3.05e-05	0.000807	CbGpPWpGaD
Labetalol—ADRB2—GPCR ligand binding—POMC—chronic kidney failure	3.05e-05	0.000807	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—PRKAG2—chronic kidney failure	3e-05	0.000792	CbGpPWpGaD
Labetalol—ADRB2—GPCR ligand binding—CCL2—chronic kidney failure	2.99e-05	0.00079	CbGpPWpGaD
Labetalol—ADRB3—GPCR downstream signaling—POMC—chronic kidney failure	2.97e-05	0.000786	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—F2—chronic kidney failure	2.96e-05	0.000783	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—PRKAG2—chronic kidney failure	2.93e-05	0.000775	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—AGXT—chronic kidney failure	2.9e-05	0.000766	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—GATM—chronic kidney failure	2.9e-05	0.000766	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—COL4A3—chronic kidney failure	2.84e-05	0.000751	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—HBEGF—chronic kidney failure	2.78e-05	0.000735	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—COL4A3—chronic kidney failure	2.78e-05	0.000735	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—HBEGF—chronic kidney failure	2.77e-05	0.000732	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—HBEGF—chronic kidney failure	2.72e-05	0.000719	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—CRHR1—chronic kidney failure	2.71e-05	0.000717	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—POMC—chronic kidney failure	2.7e-05	0.000714	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—AVP—chronic kidney failure	2.65e-05	0.000702	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—CRHR1—chronic kidney failure	2.65e-05	0.000701	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—ACAT1—chronic kidney failure	2.65e-05	0.000701	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—CCL2—chronic kidney failure	2.64e-05	0.000698	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—LRP2—chronic kidney failure	2.6e-05	0.000687	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—AVP—chronic kidney failure	2.6e-05	0.000686	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—LRP2—chronic kidney failure	2.54e-05	0.000672	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—EDN1—chronic kidney failure	2.52e-05	0.000667	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—CCL5—chronic kidney failure	2.5e-05	0.000662	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—PTH—chronic kidney failure	2.48e-05	0.000655	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—EDN1—chronic kidney failure	2.47e-05	0.000653	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—MLXIPL—chronic kidney failure	2.46e-05	0.000652	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—CCL5—chronic kidney failure	2.45e-05	0.000648	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—PTH—chronic kidney failure	2.42e-05	0.000641	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—CYBB—chronic kidney failure	2.41e-05	0.000639	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—AVP—chronic kidney failure	2.41e-05	0.000637	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—AVP—chronic kidney failure	2.4e-05	0.000634	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—CYBB—chronic kidney failure	2.36e-05	0.000625	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—AVP—chronic kidney failure	2.36e-05	0.000623	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—EDN1—chronic kidney failure	2.29e-05	0.000606	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—FGF23—chronic kidney failure	2.29e-05	0.000605	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—EDN1—chronic kidney failure	2.28e-05	0.000603	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—CCL5—chronic kidney failure	2.27e-05	0.000601	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—CCL5—chronic kidney failure	2.26e-05	0.000599	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—CCR5—chronic kidney failure	2.26e-05	0.000597	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—SLC22A2—chronic kidney failure	2.25e-05	0.000596	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—EDN1—chronic kidney failure	2.24e-05	0.000593	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—FGF23—chronic kidney failure	2.24e-05	0.000592	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—CCL5—chronic kidney failure	2.22e-05	0.000588	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—LPL—chronic kidney failure	2.21e-05	0.000585	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—CCR5—chronic kidney failure	2.21e-05	0.000584	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—NPY—chronic kidney failure	2.15e-05	0.000569	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—NPY—chronic kidney failure	2.11e-05	0.000557	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—NGF—chronic kidney failure	2.1e-05	0.000554	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—ABCG1—chronic kidney failure	2.09e-05	0.000554	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—OXT—chronic kidney failure	2.08e-05	0.000549	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—CRH—chronic kidney failure	2.08e-05	0.000549	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—PIP5K1B—chronic kidney failure	2.05e-05	0.000542	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—CCR5—chronic kidney failure	2.05e-05	0.000542	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—CCR5—chronic kidney failure	2.04e-05	0.000539	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—OXT—chronic kidney failure	2.03e-05	0.000537	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—CRH—chronic kidney failure	2.03e-05	0.000537	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—ARG2—chronic kidney failure	2.01e-05	0.000531	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—CCR5—chronic kidney failure	2e-05	0.00053	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—NCF1—chronic kidney failure	1.99e-05	0.000526	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—LCAT—chronic kidney failure	1.97e-05	0.000521	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—NPS—chronic kidney failure	1.97e-05	0.000521	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—NCF1—chronic kidney failure	1.95e-05	0.000515	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—F2—chronic kidney failure	1.94e-05	0.000512	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—DRD1—chronic kidney failure	1.93e-05	0.000511	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—NPS—chronic kidney failure	1.93e-05	0.000509	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—F2—chronic kidney failure	1.89e-05	0.000501	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—DRD1—chronic kidney failure	1.89e-05	0.0005	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—CYBA—chronic kidney failure	1.87e-05	0.000495	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—CYBA—chronic kidney failure	1.83e-05	0.000484	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—DDC—chronic kidney failure	1.81e-05	0.000478	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—POMC—chronic kidney failure	1.76e-05	0.000466	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—F2—chronic kidney failure	1.76e-05	0.000465	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—PRKD1—chronic kidney failure	1.76e-05	0.000464	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—CYP2B6—chronic kidney failure	1.76e-05	0.000464	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—PRKAG2—chronic kidney failure	1.76e-05	0.000464	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—F2—chronic kidney failure	1.75e-05	0.000463	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—POMC—chronic kidney failure	1.72e-05	0.000456	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—F2—chronic kidney failure	1.72e-05	0.000455	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—IRS1—chronic kidney failure	1.65e-05	0.000438	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—SREBF2—chronic kidney failure	1.64e-05	0.000435	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—HBEGF—chronic kidney failure	1.64e-05	0.000434	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—HBEGF—chronic kidney failure	1.61e-05	0.000425	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—POMC—chronic kidney failure	1.6e-05	0.000423	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—POMC—chronic kidney failure	1.59e-05	0.000421	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—GCKR—chronic kidney failure	1.59e-05	0.00042	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—ABCC3—chronic kidney failure	1.59e-05	0.00042	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—CCL2—chronic kidney failure	1.57e-05	0.000414	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—POMC—chronic kidney failure	1.57e-05	0.000414	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—CCL2—chronic kidney failure	1.56e-05	0.000412	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—LPIN1—chronic kidney failure	1.55e-05	0.000411	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—IGF1—chronic kidney failure	1.53e-05	0.000405	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—CCL2—chronic kidney failure	1.53e-05	0.000405	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—LRP2—chronic kidney failure	1.52e-05	0.000403	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—CYP2C18—chronic kidney failure	1.52e-05	0.000403	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—SERPINE1—chronic kidney failure	1.46e-05	0.000385	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—KRAS—chronic kidney failure	1.44e-05	0.000381	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—AVP—chronic kidney failure	1.42e-05	0.000376	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—AVP—chronic kidney failure	1.39e-05	0.000368	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—NOS3—chronic kidney failure	1.39e-05	0.000368	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—EDN1—chronic kidney failure	1.35e-05	0.000358	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—CCL5—chronic kidney failure	1.34e-05	0.000355	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—EDN1—chronic kidney failure	1.32e-05	0.00035	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—CCL5—chronic kidney failure	1.31e-05	0.000348	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—LPL—chronic kidney failure	1.31e-05	0.000347	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—RELA—chronic kidney failure	1.31e-05	0.000346	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—CPT1A—chronic kidney failure	1.29e-05	0.000342	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—LPL—chronic kidney failure	1.28e-05	0.00034	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—LIPC—chronic kidney failure	1.26e-05	0.000334	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—CYP2C19—chronic kidney failure	1.26e-05	0.000334	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—NGF—chronic kidney failure	1.24e-05	0.000329	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—NGF—chronic kidney failure	1.22e-05	0.000322	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—CCR5—chronic kidney failure	1.21e-05	0.00032	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—CCR5—chronic kidney failure	1.18e-05	0.000313	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—IL6—chronic kidney failure	1.17e-05	0.00031	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—SCARB1—chronic kidney failure	1.17e-05	0.000308	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—PTGS1—chronic kidney failure	1.15e-05	0.000305	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—SREBF1—chronic kidney failure	1.13e-05	0.000299	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—NFKB1—chronic kidney failure	1.1e-05	0.000292	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—HMGCR—chronic kidney failure	1.1e-05	0.000291	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—FASN—chronic kidney failure	1.08e-05	0.000285	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—F2—chronic kidney failure	1.04e-05	0.000275	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—F2—chronic kidney failure	1.02e-05	0.000269	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—VEGFA—chronic kidney failure	1e-05	0.000265	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—CYP3A4—chronic kidney failure	9.97e-06	0.000264	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—IRS1—chronic kidney failure	9.82e-06	0.00026	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—ABCA1—chronic kidney failure	9.81e-06	0.000259	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—IRS1—chronic kidney failure	9.61e-06	0.000254	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—POMC—chronic kidney failure	9.46e-06	0.00025	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—CCL2—chronic kidney failure	9.25e-06	0.000245	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—POMC—chronic kidney failure	9.25e-06	0.000245	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—TGFB1—chronic kidney failure	9.19e-06	0.000243	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—IGF1—chronic kidney failure	9.1e-06	0.000241	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—CCL2—chronic kidney failure	9.05e-06	0.000239	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—IGF1—chronic kidney failure	8.9e-06	0.000235	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—SERPINE1—chronic kidney failure	8.64e-06	0.000229	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—KRAS—chronic kidney failure	8.55e-06	0.000226	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—KRAS—chronic kidney failure	8.51e-06	0.000225	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—SERPINE1—chronic kidney failure	8.45e-06	0.000224	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—KRAS—chronic kidney failure	8.37e-06	0.000221	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—CAT—chronic kidney failure	8.3e-06	0.00022	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—NOS3—chronic kidney failure	8.25e-06	0.000218	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—ABCB1—chronic kidney failure	8.08e-06	0.000214	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—NOS3—chronic kidney failure	8.07e-06	0.000213	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—RELA—chronic kidney failure	7.76e-06	0.000205	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—LPL—chronic kidney failure	7.69e-06	0.000204	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—RELA—chronic kidney failure	7.59e-06	0.000201	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—CYP1A1—chronic kidney failure	7.43e-06	0.000197	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—IL6—chronic kidney failure	6.96e-06	0.000184	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—MTHFR—chronic kidney failure	6.93e-06	0.000183	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—IL6—chronic kidney failure	6.92e-06	0.000183	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—IL6—chronic kidney failure	6.81e-06	0.00018	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—PPARA—chronic kidney failure	6.8e-06	0.00018	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—NFKB1—chronic kidney failure	6.55e-06	0.000173	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—NFKB1—chronic kidney failure	6.4e-06	0.000169	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—VEGFA—chronic kidney failure	5.94e-06	0.000157	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—VEGFA—chronic kidney failure	5.81e-06	0.000154	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—POMC—chronic kidney failure	5.54e-06	0.000147	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—TGFB1—chronic kidney failure	5.45e-06	0.000144	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—TGFB1—chronic kidney failure	5.34e-06	0.000141	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—KRAS—chronic kidney failure	5.05e-06	0.000134	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—ALB—chronic kidney failure	5.05e-06	0.000134	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—KRAS—chronic kidney failure	4.94e-06	0.000131	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—NOS3—chronic kidney failure	4.83e-06	0.000128	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—PTGS2—chronic kidney failure	4.42e-06	0.000117	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—IL6—chronic kidney failure	4.11e-06	0.000109	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—IL6—chronic kidney failure	4.02e-06	0.000106	CbGpPWpGaD
